NanoRepro AG
NN6G.DE operates in the healthcare services and equipment sector, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
Business. NN6G.DE is a healthcare company operating within the Medical Equipment, Supplies & Distribution industry. The firm generates revenue through the sale of medical products, with key performance indicators including organic revenue growth, procedure volume, and gross margin. Specific details regarding operating segments, headquarters location, and geographic mix are not available. The company is listed on the Xetra exchange under the ticker NN6G.DE.
Analyst recommendations
2 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
NN6G.DE is a healthcare company operating within the Medical Equipment, Supplies & Distribution industry. The firm generates revenue through the sale of medical products, with key performance indicators including organic revenue growth, procedure volume, and gross margin. Specific details regarding operating segments, headquarters location, and geographic mix are not available. The company is listed on the Xetra exchange under the ticker NN6G.DE.
NN6G.DE exhibits a strong liquidity position, with a current ratio of 49.94, indicating a substantial ability to cover short-term liabilities with current assets. The company holds EUR 9,098,120 in cash and equivalents, and it has no long-term debt, which further supports its liquidity profile. However, the company's free cash flow is negative at EUR -2,377,530, suggesting that capital expenditures and other operational costs are outpacing cash inflows.
The company's profitability is currently negative, with a return on equity of -5.36% and a return on assets of -5.24%. These figures indicate that the company is not generating returns for its shareholders or effectively utilizing its assets to generate profit. The operating income is significantly negative at EUR -3,623,830, and the net income is also negative at EUR -2,045,760, highlighting the company's current financial challenges.
NN6G.DE's revenue is concentrated in a single business segment, as no segmental breakdown is provided in the available data. The company's geographic exposure is not explicitly detailed, but the absence of segmental or geographic diversification suggests a potential concentration risk. The company's operating cash flow is positive at EUR 9,860,300, which is a positive sign for its ability to fund operations and potentially reduce debt or invest in growth.
The company's growth trajectory is uncertain, as no specific outlook for the current or next fiscal year is provided. The absence of a clear growth strategy or financial projections makes it difficult to assess the company's future performance. The company's capital expenditure of EUR -362,600 indicates some level of investment in its operations, but the overall financial performance remains a concern.
The risk assessment for NN6G.DE indicates low liquidity and dilution risks, with no immediate filing-based liquidity or dilution flags detected. The company's dilution potential is also low, and no adjustments have been applied to its valuation metrics. The absence of significant risk factors is a positive aspect, but the company's negative profitability and free cash flow remain critical concerns.
Recent events and filings for NN6G.DE do not provide specific details on recent developments, but the company's financial performance and risk profile suggest a need for close monitoring. The company's operating cash flow and liquidity position are positive indicators, but the negative net income and return on equity highlight the need for strategic improvements.
- NN6G.DE has a strong liquidity position with a current ratio of 49.94 and no long-term debt.
- The company is currently unprofitable, with a return on equity of -5.36% and a return on assets of -5.24%.
- The company's free cash flow is negative at EUR -2,377,530, indicating that capital expenditures and operational costs are outpacing cash inflows.
- The company's revenue and geographic exposure are not diversified, suggesting a potential concentration risk.
- The company's risk assessment indicates low liquidity and dilution risks, with no immediate filing-based flags detected.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- NN6G.DE Market data — financials · 2026-05-28
- NanoRepro AG Market data — analyst estimates · 2026-05-28